ESTHER FEINSTEIN: Open Payments
NPI 1134645450 · PATERSON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$571 in 27 payments from 10 companies in 2025. Trend: 2023 $13 · 2024 $197 · 2025 $571
Food & beverage: $406Education: $165
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $219 |
| Incyte Corporation | 5 | $80 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $77 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| PFIZER INC. | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Botanix SB Inc | 1 | $19 |
| LEO Pharma Inc. | 1 | $18 |
| UCB, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
Products named: TREMFYA, OPZELURA, ILUMYA, SPEVIGO, CIBINQO, COSENTYX, SOFDRA, BLU-U.
Industry payments across NJ — which companies pay providers there.
